This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use



2018 BioInfect Conference

Location: Alderley Park Conference Centre, Alderley Park, Cheshire, SK10 4TG

Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. BioInfect will look at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.

Antimicrobial resistance could cut global GDP by 3.5%, a cumulative cost of £70bn.

We are delighted to have Perfectus Biomed, EvotecThe AMR Centre and Alderley Park sponsoring the 2018 BioInfect Conference.

With no new antibiotics having been developed in over 30 years, antimicrobial resistance is threatening the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. BioInfect will analyse the implications that is being felt the world over.

The cost of health care for patients with resistant infections is higher than care for patients with non-resistant infections due to longer duration of illness, additional tests and use of more expensive drugs. Without effective antibiotics, the success of major surgery and cancer chemotherapy would be comprised.

Join Bionow and experts in this field to discuss this complex problem and the challenges ahead.


Session Theme


08.30 - 08.50

Coffee and Registration

08.50 - 09.00

Conference Welcome

Geoff Davison, CEO, Bionow

09.00 - 09.25

Keynote Address

Werner Lanthaler, CEO, Evotec

09.25- 10.25

The Current Global Situation and how PULL and PUSH Initiatives are Developing

Session Chair: Jo Pisani, Pharmaceutical and Life Science Consulting Leader, PwC UK

Lloyd Payne, Executive Vice President, Evotec
Colm Leonard, Consultant Clinical Advisor, NICE
Peter Jackson, Executive Director, The AMR Centre
James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline
Nel Moore, Senior Consultant & Director, FWEast Consulting

10.25- 10.55

Coffee, Networking & Exhibition

10.55- 11.35

Funding opportunuties for anti-infectives

Camilla Petrycer-Hansen, Senior Associate, Novo Repair Fund
Pauline Stasiak, Investment Principal, LifeArc Seed Fund

11.35- 12.35

The Role of Diagnostics

Jonathan O'Halloran, Chief Scientific Officer, QuantuMDx
Gordon Barker, CEO, MicroBioSensor
Simon Bone, European Application Specialist, SpeeDx
Paul Chapman, Partner, Marks & Clerk
Niall McLaren, Business Development Manager, Novarum

12.35- 14.00

Lunch, Networking & Exhibition

14.00- 14.25

Keynote Address

Rich Lawson, Senior Project Manager, CARB-X

14.25 - 14.45

The Role of Big Pharma

Todd Black, Executive Director Infectious Diseases, Merck

14.45 - 15.45

Company Case Studies

Session Chair: Lloyd Payne, Executive Vice President, Evotec

David Powell, Head of Research, Summit
Michael McArthur, CSO, Procarta Biosystems
Mike Westby, CEO, Centauri Therapeutics

15.45- 16.00

Focus on the AMR Scene

Peter Jackson, Executive Director, The AMR Centre

16.00 - 16.20

Early Stage Sound-Bites

Gordon Barker, Amprologix
Timothy Schulz-Utermoehl, co-founder and Director, Pedanius
James Cass, R&D Manager, Phico Therapeutics

16.20- 17.00

Coffee, Networking and Conference Close

Delegate Fees
Premium Member: £99.00 + VAT
Member: £125.00 + VAT
Non Member: £199.00 + VAT

If you are interested in sponsorship and exhibition opportunities at the event please contact Helen Williams on 07714 168020 or at

> Register here